Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent

European Heart Journal

Volumn 22, Issue 13, 2001, Pages 1128-1135

  Loubeyre, Christophe ^a,f   Lefevre T ^b   Louvard, Y ^a   Dumas, P ^c   Piechaud J F ^b   Lanore, J J ^b   Angellier, J F ^a   Le Tarnec, J Y ^d   Karrillon, G ^a   Margenet, A ^e   Pouges C ^e   Morice, M C ^b  

^a INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^b INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^c INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^d Service d'Aide Médicale d'Urgence   (France)

^e NONE

^f INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

Author keywords

Angioplasty; Myocardial infarction; Stents; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN DERIVATIVE; RETEPLASE; STREPTOKINASE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CORONARY STENT; DOSE RESPONSE; FEMALE; GRAFT PATENCY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

EID: 0034919173     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2500     Document Type: Article

References (46)

1. The effect of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction
2. Link between the angiographic substudy and mortality outcome in a large randomized trial of myocardial reperfusion
3. Prehospital use of APSAC: Results of a placebo-controlled study
4. Prehospital thrombolysis in acute myocardial infarction
5. Feasibility, safety and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region Early Anistreptlase Trial
6. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction
7. Prehospital-initiated vs hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and intervention Trial
8. Prehospital thrombolysis: Beneficial effect of very early treatment on infarct size and left ventricular function
9. Thrombolytic therapy for acute myocardial infarction: A review
10. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
11. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: A prospective placebo-controlled angiographic study. Result of the APRICOT study
12. Consequences of reocclusion following successful reperfusion therapy in acute myocardial infarction
13. Treatment of recurrent ischemia after thrombolysis and successful reperfusion for acute myocardial infarction: Effect on in-hospital mortality and left ventricular function
14. Angiographically documented late reocclusion after successful coronary angioplasty of an infarct-related lesion is a powerful predictor of long-term mortality
15. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
16. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction
17. Thrombolysis with t-PA in acute myocardial infarction: No beneficial effects of immediate PTCA
18. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction
19. Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: A regional wall motion analysis
20. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial
21. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
22. Coronary angioplasty with or without stent implantation for acute myocardial infarction
23. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge
24. Emergency coronary artery bypass surgery following coronary angioplasty and stenting: Results of a French multicenter registry
25. Intra coronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy
26. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The access study
27. Stenting in acute coronary syndromes: A comparison of radial versus femoral access sites
28. A comparison of reteplase with alteplase for acute myocardial infarction
29. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double blind randomised trial
30. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
31. Ten-year follow-up of the first mega trial testing thrombolytic therapy in patients with acute myocardial infarction. Results of the Gruppo italiano per lo Studio della sopravvivenza nell'Infarto-1 study
32. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction
33. Long-term outcome after primary angioplasty: Report from the primary, angioplasty in myocardial infarction (PAMI-1) trial
34. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction
35. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial
36. Relationship between delay, in performing direct coronary angioplasty and early, clinical outcome in patients with acute myocardial infarction. Results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) Trial
37. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction
38. Rescue angioplasty following thrombolysis: Technical and clinical outcome in a large thrombolysis trial
39. Rescue angioplasty in the Thrombolysis in Myocardial Infarction (TIMI) 4 Trial
40. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction
41. Effect of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction
42. Glycoprotein IIb/IIIa blockade and thrombolytics: Early lessons from the SPEED and GUSTO IV trials
43. Abciximab facilitates the rate and extent of thrombolysis: Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial
44. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction
45. Coronary stenting plus platelet glycoprotein IIB/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction